MX2022009572A - Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición. - Google Patents

Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición.

Info

Publication number
MX2022009572A
MX2022009572A MX2022009572A MX2022009572A MX2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A MX 2022009572 A MX2022009572 A MX 2022009572A
Authority
MX
Mexico
Prior art keywords
pyrrolo
pyridine
hearing loss
methods
ameliorating hearing
Prior art date
Application number
MX2022009572A
Other languages
English (en)
Inventor
John David Ginn
Rui Liang
Ksenia Gnedeva
A James Hudspeth
Nathaniel Kastan
Peter T Meinke
David John Huggins
Nigel John Liverton
Leigh Ashley Baxt
Robert Walter Myers
Original Assignee
Univ Rockefeller
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rockefeller filed Critical Univ Rockefeller
Publication of MX2022009572A publication Critical patent/MX2022009572A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describe N-(tiazol-2(3H)-iliden 3-sustituido)-1H-pirrolo[2,3-b] piridin-3-carboxamidas y N-(oxazol-2(3H)- iliden 3-sustituido)-1H- pirrolo[2,3-b]piridin-3-carboxamidas (ver Fórmulas) Los compuestos activan Yap e inhiben las cinasas Lats. Por lo tanto, son útiles para tratar la pérdida de audición.
MX2022009572A 2020-02-05 2021-02-05 Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición. MX2022009572A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202062970425P 2020-02-05 2020-02-05
PCT/US2021/016848 WO2021158936A1 (en) 2020-02-05 2021-02-05 Pyrrolo [2,3-b]pyridine-3-carboxamide compositions and methods for ameliorating hearing loss

Publications (1)

Publication Number Publication Date
MX2022009572A true MX2022009572A (es) 2022-12-13

Family

ID=77199407

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022009572A MX2022009572A (es) 2020-02-05 2021-02-05 Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición.

Country Status (8)

Country Link
US (1) US20230137893A1 (es)
EP (1) EP4100008A4 (es)
JP (1) JP2023512823A (es)
CN (1) CN115515579A (es)
AU (1) AU2021215925A1 (es)
CA (1) CA3170121A1 (es)
MX (1) MX2022009572A (es)
WO (1) WO2021158936A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2023015156A1 (en) * 2021-08-02 2023-02-09 Hudspeth A James Pyrrolopyridine-3- and 4-carboxamide compositions and methods for cellular proliferation

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2888848B1 (fr) * 2005-07-22 2007-09-28 Sanofi Aventis Sa Derives de n-(arylalkyl)-1h-pyrrrolopyridine-2-carboxamides, leur preparation et leur application en therapeutique
EP1963320A1 (en) * 2005-12-07 2008-09-03 OSI Pharmaceuticals, Inc. Pyrrolopyridine kinase inhibiting compounds
PE20081581A1 (es) * 2006-12-21 2008-11-12 Plexxikon Inc COMPUESTOS PIRROLO[2,3-b]PIRIDINAS COMO MODULADORES DE QUINASA
TWI667233B (zh) * 2013-12-19 2019-08-01 德商拜耳製藥公司 新穎吲唑羧醯胺，其製備方法、含彼等之醫藥製劑及其製造醫藥之用途
GB201602854D0 (en) * 2016-02-18 2016-04-06 Mission Therapeutics Ltd Novel compounds
JOP20190257A1 (ar) * 2017-04-28 2019-10-28 Novartis Ag مركبات أريل غير متجانسة ثنائية الحلقة مندمجة 6-6 واستخدامها كمثبطات lats

Also Published As

Publication number Publication date
CN115515579A (zh) 2022-12-23
US20230137893A1 (en) 2023-05-04
EP4100008A1 (en) 2022-12-14
JP2023512823A (ja) 2023-03-29
WO2021158936A1 (en) 2021-08-12
CA3170121A1 (en) 2021-08-12
EP4100008A4 (en) 2024-02-07
AU2021215925A1 (en) 2022-09-08

Similar Documents

Publication Publication Date Title
MXPA06001134A (es) Inhibidores de la actividad de la proteina cinasa b.
MX2009012788A (es) Metodos y composiciones para estimular celulas.
UA91716C2 (ru) НОВАЯ КРИСТАЛЛИЧЕСКАЯ ФОРМА ПРОИЗВОДНОГО ПИРИДАЗИНО[4,5-b]ИНДОЛА
WO2006126081A3 (en) Pyridino [2 , 3-b] pyrazinones as pde-5 inhibitors
MX2021001952A (es) Compuestos de pirazolo[3,4-b]piridina como inhibidores de cinasas tam y met.
RS52824B (es)
WO2006113498A3 (en) 2-amino-quinaz0lin-5-ones as hsp90 inhibitors useful in treating proliferation diseases
NO20081133L (no) Tieno[2,3-B]-pyridin-5-karbonitriler som protein kinase inhibitorer
WO2006065280A3 (en) Isoxazole, dihydroisoxazole, and oxadiazole substituted imidazo ring compounds and methods
UA89968C2 (uk) Похідні піроло[3,2-d]-піримідин-4-ону та їх застосування у терапії
WO2006098961A3 (en) Fused thieno [2, 3-b] pyridine and thiazolo [5, 4-b] pyridine compounds for inhibiting ksp kinesin activity
MY146989A (en) Kinase inhibitors
UA106054C2 (uk) ЗАМІЩЕНІ ПІРАЗОЛО[1,5-a]ПІРИМІДИНОВІ СПОЛУКИ ЯК ІНГІБІТОРИ TРK-КІНАЗИ
WO2006086634A3 (en) Oxime and hydroxylamine substituted imidazo[4,5-c] ring compounds and methods
WO2006113837A3 (en) Inhibitors of akt activity
NO20082511L (no) Nye pyridopyraziner og deres anvendelse som kinasemodulatorer
HK1078850A1 (en) Novel alkoxypyridine-derivatives
YU73101A (sh) Pirazolobenzodiazepini kao inhibitori cdk2
AU2006287480A8 (en) Bicyclic derivatives as modulators of voltage gated ion channels
MX2009006885A (es) Derivados de pirrolo[3,2-a]piridina para inhibir la actividad de la proteina cinesina del huso.
MY150747A (en) Pyrido[2,3-d] pyrimidin-7-one compounds as inhibitors of pi3k-alpha for the treatment of cancer
MX2022009572A (es) Composiciones de pirrolo[2,3-b]piridina-3-carboxamida y métodos para mejorar la pérdida de audición.
EP3976607A4 (en) SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AND PYRAZOLO[3,4-B]PYRIDINE DERIVATIVES AS PROTEIN KINAS INHIBITORS
MY130736A (en) Imidazo(4,5-c) pyridin-4-one derivatives
MX2022000279A (es) Regimenes de antagonistas del receptor de estrogeno.